HMG-CoA Reductase Inhibitor [EPC]

316490 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

#	Side effect	Count
0	FATIGUE	16676
1	NAUSEA	15844
2	DRUG INEFFECTIVE	15673
3	DYSPNOEA	15202
4	DIARRHOEA	14044
5	DIZZINESS	13420
6	ASTHENIA	11421
7	PAIN	11164
8	FALL	10920
9	MYALGIA	10700

See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	IMMUNE-MEDIATED NECROTISING MYOPATHY	256	0.4621
1	IMMUNE-MEDIATED MYOSITIS	251	0.3984
2	MYOPATHY	1635	0.2588
3	CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER	221	0.2570
4	HYPERPARATHYROIDISM SECONDARY	514	0.2468
5	NEPHROGENIC ANAEMIA	914	0.2294
6	RHABDOMYOLYSIS	6901	0.2246
7	REBOUND ACID HYPERSECRETION	482	0.1687
8	POLYMYOSITIS	204	0.1518
9	MYOSITIS	868	0.1489

See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]